Silica Filler for CCL: How It Improves Copper Clad Laminate Performance

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica as an Adsorbent: How It Works and Common Applications
  • Keywords: fused silica sand
  • Published: 2026-11-20 03:19:38
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
In recent years, mesoporous silica nanocarriers have attracted great interest in pharmaceutical science because of their advantageous properties. Straightforward synthesis, low production cost, and tunable physicochemical properties characterize them. Their behavior in the human body, including targeting possibilities, can be influenced by particle size, particle morphology, pore size, internal structure, and surface chemistry. By modifying the surface functional groups and the surface charge, targeted therapy is achievable in several medical conditions. A wide range of drug loading methods is available (whether solvent-based or solvent-free techniques), so the most appropriate method can be selected, and higher drug concentration can be encapsulated, enhancing loading efficiency. Nevertheless, their formulation for different delivery routes, such as dermal, pulmonary, or the most favorable oral administration, is very difficult due to their large particular surface, adhesivity, and low density, which leads to poor powder flow properties, posing a huge difficulty in the manufacturing and formulation of solid dosage forms. Agglomeration of the particles by granulation or pelletization is a brilliant remedy for enhancing flowability. Concluding this, the granulation process of mesoporous silica has to be investigated and optimized to sustain the initially high porosity and high particular surface area of the material.

What Is Tetraethyl Orthosilicate? Properties, Uses and Role in Silica Synthesis

Silica as a Flow Agent: How It Improves Powder Flowability
One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
CMP Slurry Silica: Colloidal vs Fumed Silica for Chemical Mechanical Polishing
Nano Silica Supplier: How to Verify Particle Size, Purity and Consistency
Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook

What Is Micro Silica? Properties, Specifications and Uses in Concrete and Refractories

What is silica (SiO₂)?

Cab-O-Sil M-5 Utilizing DE as a Pesticide

What is the difference between fumed silica and precipitated silica?

silica price 61. Tzankov B., Voycheva C., Tosheva A., Stefanova D., Tzankova V., Spassova I., Kovacheva D., Avramova K., Tzankova D., Yoncheva K. Novel oleogels for topical delivery of quercetin based on mesoporous silica MCM-41 and HMS particles. J. Drug Deliv. Sci. Technol. 2023;86:104727. doi: 10.1016/j.jddst.2023.104727. [ DOI ] [ Google Scholar ]

What drives silica raw material prices?

silica thickening agent 47. Aulifa D.L., Saepudin A.H., Margaretha P., Khairinisa M.A., Budiman A. Characterization of Alpha Mangostin Loaded-Mesoporous Silica Nanoparticle and the Impact on Dissolution and Physical Stability. Nanotechnol. Sci. Appl. 2025;18:1-13. doi: 10.2147/NSA.S499007. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "Silica Market Size 2026: Global Value, Growth Rate and Key Segments ." Published 2026-11-20 03:19:38. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.